Bolt Biotherapeutics, Inc.

SEC 4 · Filed

0001104659-26-129252Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Nov 17, 2026

Purchase by Coastlands Capital LP

Security
Common Stock
Code
P
Shares
20,000
Price per share
5.75Reported 5.7499
Structured facts
{
  "code": "P",
  "date": "2026-11-17",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F2": "Coastlands Capital LP (\"Coastlands\") and Coastlands Capital GP LLC (the \"General Partner\") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the \"Partnership\"). Coastlands Capital LLC (\"Coastlands GP\") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person\u0027s pecuniary interest therein."
  },
  "owners": [
    {
      "cik": "0002068530",
      "name": "Coastlands Capital LP",
      "roles": [
        "ten_percent_owner"
      ],
      "title": null
    }
  ],
  "ownership": "I",
  "post_shares": "515510",
  "price": "5.7499",
  "row": 2,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "20000",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Nov 16, 2026

Purchase by Coastlands Capital LP

Security
Common Stock
Code
P
Shares
33,094
Price per share
5.89
Structured facts
{
  "code": "P",
  "date": "2026-11-16",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $5.8000 to $5.9136. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the reporting persons will provide full information regarding the number of shares purchased at each separate price.",
    "F2": "Coastlands Capital LP (\"Coastlands\") and Coastlands Capital GP LLC (the \"General Partner\") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the \"Partnership\"). Coastlands Capital LLC (\"Coastlands GP\") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person\u0027s pecuniary interest therein."
  },
  "owners": [
    {
      "cik": "0002068530",
      "name": "Coastlands Capital LP",
      "roles": [
        "ten_percent_owner"
      ],
      "title": null
    }
  ],
  "ownership": "I",
  "post_shares": "495510",
  "price": "5.89",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "33094",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}